Luger A
Derm Beruf Umwelt. 1980;28(2):48-50.
Investigations on 404742 sera by the Automated Micro-Haemagglutination Assay with Treponema pallidum Antigen (AMHA-TP) and the VDRL-test for screening revealed 9848 (2,43%) reactive results in one of the two or in both methods. All reactive samples were checked by the FTA-ABS-test. A reactivity in both, the AMHA-TP and the FTA-ABS indicates a former infection with Treponema pallidum. The VDRL failed to point out reactivity in 4226 of 7474 sera (56,5%) deriving from syphilitic donors. The agglutination in the AMHA-TP can be inhibited by a protein of low molecular weight which occurs appearently in extraordinarily rare cases and was found in one sample only until now. The margin of error of the screening procedure by using the AMHA-TP and the VDRL amounts to 0,04%-0,38% of all samples examined.
采用梅毒螺旋体抗原自动微量血凝试验(AMHA-TP)和性病研究实验室玻片试验(VDRL)对404742份血清进行筛查,结果显示,两种方法中的一种或两种检测呈阳性的结果有9848例(2.43%)。所有阳性样本均通过荧光螺旋体抗体吸收试验(FTA-ABS)进行检测。AMHA-TP和FTA-ABS均呈阳性表明曾感染梅毒螺旋体。在7474份来自梅毒患者的血清中,VDRL检测有4226份(56.5%)呈阴性。AMHA-TP中的凝集反应可被一种低分子量蛋白质抑制,这种蛋白质似乎极其罕见,到目前为止仅在一份样本中发现。使用AMHA-TP和VDRL进行筛查的误差范围为所有检测样本的0.04% - 0.38%。